JAKi and bDMARDs treatment persistences
| Drug (n=582) | Median persistence, days [95CI%] | HR [95CI%]; p-value |
|---|---|---|
| JAKi (n=166) | 428 [262–609] | - |
| TNFi (n=180) | 281 [210–378] | 1.19 [0.91–1.56]; p=0.215 |
| IL6i (n=124) | 381 [263–504] | 1.06 [0.79–1.43]; p=0.695 |
| CD80/86i (n=64) | 221 [177- 321] | 1.40 [0.99–1.98]; p=0.054 |
| CD20i (n=48) | 692 [516–1,146] | 0.77 [0.50–1.18]; p=0.227 |